Companies /Healthcare

Moderna Inc

NASDAQ: MRNA Biotechnology
$214.17
▲ $6.20 (+2.98%) today
Markets closed · 6:23am ET
24/7 Rating SELL
Our 12-month price target
$149.16
−28.3% downside by Oct 2027
Price when calculated $207.97 Oct 28, 2026
Street consensus $138.37 23 analysts
Ours vs. the Street +7.8% Our target vs. consensus

Set by 24/7 Wall St.’s proprietary analysis of professional targets, profit trajectory, sector, risk, and retail attention. Recalculated at least weekly and after every earnings report.

How we calculate it →
12-Month Projection Historical Optimistic Target Conservative
$60$120$180Oct 2025Oct 2027Oct 28$188.39$149.16$106.50
$60$120$180Oct 2025Oct 2027Oct 28$188.39$149.16$106.50

Analyst Sentiment

23ANALYSTS
Buy522%
Hold1565%
Sell313%
The Bottom Line

Moderna faces potential headwinds at current valuations. Our analysis suggests 28.3% downside risk to our $149.16 target. Investors may want to consider reducing exposure or waiting for a better entry point.

The 24/7 Factor

Base Growth
Conservative growth baseline (reduced to avoid double-counting P/E growth)
1.05×
Sector Momentum
Defensive growth with aging population tailwinds
1.10×
Analyst Consensus
Mixed analyst views
+0.5%
Earnings Growth
Significant earnings decline
−3.0%
Volatility Adjustment
Average volatility
−0.2%
Social Sentiment
Cautious retail sentiment
−1.2%
Read our full methodology →

5-Year Projection

Long-Term Forecast Optimistic Target Conservative
$80$120$160$200’26’27’28’29’30’31$199.20$116.19$84.22
$80$120$160$200’26’27’28’29’30’31$199.20$116.19$84.22

Prediction History

MRNA Price Target History Our Target Stock Price
$50$100$150$200Jul 31Oct 23$141.55$200.10
$50$100$150$200Jul 31Oct 23$141.55$200.10
Date Price Target Stock Price Rating Upside
$141.55 $200.10 SELL −29.3%
$135.48 $218.01 SELL −37.9%
$132.62 $225.00 SELL −41.1%
$133.10 $190.01 SELL −30.0%
$131.64 $198.88 SELL −33.8%
$132.71 $154.04 HOLD −13.9%
$132.71 $143.97 HOLD −7.8%
$125.28 $145.55 HOLD −13.9%

Social Sentiment

35/100
Sentiment Score
Bearish
Retail Mood
Low
Discussion Activity

Frequently Asked Questions

What is the MRNA stock price prediction for 2030?

Looking ahead to 2030, our model projects MRNA could trade at an average price of $130.54, with a potential range between $97.90 and $163.17. This represents a potential 37.2% decline from today’s price. Long-term forecasts depend heavily on company execution, competitive dynamics, and broader market conditions.

Is MRNA a buy, sell, or hold right now?

24/7 Wall St. currently rates MRNA as a SELL. Significant downside (-28.3%) Among Wall Street analysts, 5 rate it Buy, 15 rate it Hold, and 3 rate it Sell.

What is the MRNA stock price target in an optimistic scenario?

Our optimistic scenario for MRNA projects a price of $188.39 over the next 12 months. Even under favorable conditions, this suggests limited upside from today’s price of $207.97, indicating the stock may currently be trading near or above fair value.

What is the downside risk for MRNA stock?

In our conservative scenario, MRNA could trade as low as $106.50 over the next 12 months, representing a 48.8% decline from current levels. This scenario accounts for potential headwinds including earnings misses, competitive pressures, or broader market weakness.

Projections are estimates based on current data, updated daily. Not investment advice. Learn how we calculate these projections →